FDA changes advisory panel rules

April 26, 2010 by MassDevice staff

The Food & Drug Administration is changing the way its advisory panels deliberate and vote on medical devices under review at the federal watchdog.

FDA logo

The Food & Drug Administration is making changes to the way its advisory panels deliberate over and vote on medical devices under review by the federal watchdog agency.

As of May 1, the FDA is instituting new procedures for the panels, groups of experts assembled to review and discuss data and information on devices undergoing pre-market review.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp